On Wednesday, I joined families of children with life threatening diseases to discuss the need for faster approval of experimental medication for rare diseases and to announce my support of the Faster Access to Specialized Treatments (FAST) Act.
The FAST Act is a bipartisan proposal to expedite the Food and Drug Administration (FDA) approval process for new treatments for incurable diseases like Duchenne Muscular Dystrophy, Alzheimer's, and Parkinson's. By approving these medications more quickly, we can give hope to those suffering from these debilitating illnesses.
Joining me at this announcement were representatives from Suneel's Light Foundation to show their support for this legislation. Suneel's Light, a nonprofit organization committed to funding research for Duchenne Muscular Dystrophy, is named for Suneel Ram, a 15-year boy battling Duchene Muscular Dystrophy, who also joined us. I will continue my strong support of this legislation and will continue to fight for its passage and implementation.